Taihe 太禾 Emtricitabine/Tenofovir 200mg/300mg | Anhui Biochem Generic | GLT

Generic Information: Taihe 太禾 (China)

Taihe (太禾) is Anhui Biochem Bio-pharmaceutical's generic fixed-dose combination of emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg, approved by the National Medical Products Administration and cleared through China's generic consistency evaluation. Supplied as thirty film-coated tablets per box, it is one of the domestically produced versions of the originator Truvada that has widened access to this essential two-drug backbone inside China's HIV program.

What Is 太禾 (Taihe) Used For?

太禾 is prescribed both to treat and to help prevent HIV-1. In treatment it is combined with other antiretroviral medicines to suppress HIV-1 in adults and adolescents weighing at least 35 kg. In prevention it is taken as pre-exposure prophylaxis to lower the chance of acquiring HIV-1 through sex in people who test negative. Its domestic manufacture helps keep the per-tablet cost low, an important factor for lifelong therapy.

How Does 太禾 Work?

The two active components attack the same viral enzyme, reverse transcriptase, through two related nucleoside chemistries. Emtricitabine mimics cytidine and tenofovir mimics adenosine; once phosphorylated inside cells, each is mistaken by the enzyme for a natural building block and inserted into the growing viral DNA, where it blocks further extension and stops replication. This paired mechanism is the backbone of many modern HIV regimens.

Indications

太禾 is indicated, in combination with other antiretroviral agents, for the treatment of HIV-1 infection in adults and pediatric patients of at least 35 kg, and for pre-exposure prophylaxis to reduce the risk of sexually acquired HIV-1 in at-risk, HIV-negative adults and adolescents of at least 35 kg. As with the originator, it is not a hepatitis B treatment, and stopping it in HBV co-infection can trigger a flare.

Dosage

One tablet is taken once daily, with or without food, providing 200 mg emtricitabine and 300 mg tenofovir disoproxil fumarate. Kidney function is assessed before and during therapy, with a longer dosing interval in moderate impairment. For PrEP, a negative HIV test is confirmed before starting and repeated on a regular schedule while the medicine continues.

Side Effects

Nausea, diarrhea, headache, dizziness and fatigue are the most common early reactions and generally improve as the body adapts. The principal long-term concerns are kidney dysfunction and reduced bone mineral density, both attributable mainly to tenofovir disoproxil, so monitoring is routine. Rare but serious warnings include lactic acidosis with liver enlargement and a hepatitis B flare after discontinuation.

Storage

太禾 tablets are stored at room temperature in their original packaging, away from moisture and heat, with no refrigeration needed. Ambient-condition shipping is therefore straightforward, and GLT dispatches from a Hong Kong-licensed facility with batch documentation and a certificate of analysis.

Why Choose 太禾 Through GLT?

Anhui Biochem's NMPA-approved, consistency-evaluated generic delivers the emtricitabine/tenofovir backbone at a domestic-Chinese price point, an economical route for self-funded patients facing a lifetime of treatment. GLT's Hong Kong base and China-focused supply model make this product readily accessible to overseas buyers seeking a dependable, documented Chinese generic.

How to Order

To order 太禾 (Taihe, emtricitabine/tenofovir disoproxil fumarate) from GLT, contact us on WhatsApp at +86 15234153837 or by email at [email protected]. We confirm stock, pack options and delivery timelines to your country, and dispatch from a Hong Kong-licensed facility.

FAQ

Is 太禾 the same as Truvada? It is a Chinese generic with the same two active ingredients and strengths as the originator Truvada, cleared through consistency evaluation.

Is it affordable for long-term use? Domestic manufacture keeps its price lower than the brand product, a key benefit for lifelong HIV therapy.

Can it be used for PrEP? Yes — in HIV-negative people it lowers the risk of sexually acquired HIV-1, provided testing rules are followed.